RETRACTION: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites (Retraction of Vol 10, Pg 8044, 2020)

被引：0
|
作者：
Wang, Maorong [1 ,2 ]
Yao, Ping [2 ]
Gao, Minpeng [3 ]
Jin, Jian [4 ]
Yu, Yerong [1 ,4 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Endocrinol, Chengdu 610041, Sichuan, Peoples R China
[2] Hubei Univ Nationalities, Dept Endocrinol, Affiliated Hosp, Enshi 445000, Hubei, Peoples R China
[3] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China
[4] Jiangnan Univ, Wuxi, Jiangsu, Peoples R China
来源：
RSC ADVANCES | 2024年 / 14卷 / 03期
关键词：
D O I：
10.1039/d3ra90124f
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：1625 / 1625
页数：1
相关论文
共 3 条
  • [1] Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites (Expression of Concern of Vol 10, Pg 8044, 2020)
    Wang, Maorong
    Yao, Ping
    Gao, Minpeng
    Jin, Jian
    Yu, Yerong
    RSC ADVANCES, 2022, 12 (51) : 33348 - 33348
  • [2] RETRACTED: Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites (Publication with Expression of Concern. See vol. 12, pg. 33348, 2022) (Retracted Article)
    Wang, Maorong
    Yao, Ping
    Gao, Minpeng
    Jin, Jian
    Yu, Yerong
    RSC ADVANCES, 2020, 10 (14) : 8044 - 8053
  • [3] Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites
    Li, Caina
    Yang, Miaomiao
    Wang, Xiaofeng
    Zhang, Hua
    Yao, Chenjiang
    Sun, Sujuan
    Liu, Quan
    Pan, Hao
    Liu, Shuainan
    Huan, Yi
    Li, Shengnan
    Cao, Jun
    Wang, Xing
    Guo, Yong
    Guo, Nan
    Jing, Shuqian
    Zhang, Cheng
    Shen, Zhufang
    BIOCHEMICAL PHARMACOLOGY, 2018, 150 : 46 - 53
1